NCT01647646已完成4 期
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma: Symbicort SMART, or Other ICS/LABA With as Needed SABA
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 200
- 主要终点
- the percentage of asthma total and well control
研究概览
简要总结
In real life, the investigators will be using different strategies including SMART therapy or other ICS/LABA (medium and high dose) therapy and measure the efficacy for asthma control.
详细描述
- All not-well controlled asthma patients would include the study.
- We will compare three ways of asthma control including SMART, fixed doses with regular doses and fixed doses with higher doses
- We will evaluate the efficacy/safety for these not-well controlled patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •asthma not well control
排除标准
- 未提供
研究组 & 干预措施
Symbicort
Active Comparator
We will evaluate the efficacy fot Symbicort use. The usage was 2 doses bid for one year period.
Intervention drug: Seretide fixed doses therapy
干预措施: Seretide (Drug)
Seretide
Experimental
In non-well asthma controlled patients, experimental study with Seretide regular doses (125 2 doses bid for one year) and higher doses (250 2 doses bid) for one year
干预措施: Seretide (Drug)
结局指标
主要结局
the percentage of asthma total and well control
时间窗: one year
F/U clinical asthma control status and percentage of Acute exacerbation
次要结局
- percentage of asthma acute exacerbation(one year)
研究者
Shih-Lung Cheng
Chief, Division of Pulmonary Medicine
Far Eastern Memorial Hospital
相似试验
招募中
不适用
Real-world evaluation of optimal medical therapy after percutaneous coronary intervention.JPRN-UMIN000020783Graduate School of Medical Sciences, Kumamoto University2,000
招募中
不适用
Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)Marginal Zone LymphomaNCT06534463Ruijin Hospital500
招募中
不适用
Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast CancerESR1 Gene MutationAdvanced Breast CancerNCT06548919SciClone Pharmaceuticals450
已完成
不适用
Real Life Effectiveness in Patients With Not Optimally Controlled AsthmaAsthmaNCT00784953AstraZeneca842
招募中
不适用
A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the OvaryOvarian Clear Cell CarcinomaNCT06279104Tongji Hospital150